• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Fred Pennic, Editor-in Chief | HIT Consultant

Fred Pennic is the Founder and Editor-in-Chief of HIT Consultant.

UK Startup OrganOx Secures $32.6M for Liver Transplantation Device

by Fred Pennic 07/17/2023 Leave a Comment

UK Startup OrganOx Secures $32.6M for Liver Transplantation Device

What You Should Know:  - OrganOx, a United Kingdom-based medical technology company committed to making every donated organ count with metra®, a fully automated normothermic machine perfusion (NMP) device for liver transplantation raises £25M ($32.6M USD) in a growth round led by Lauxera Capital Partners (“Lauxera”) with support from existing investors. - The proceeds from the funding will enable OrganOx to significantly expand its commercial footprint across strategically key areas
Read More

PE Firm Thoma Bravo Makes Strategic Investment in Bluesight & Medacist Acquisition

by Fred Pennic 07/17/2023 Leave a Comment

PE Firm Thoma Bravo Makes Strategic Investment in Bluesight & Medacist Acquisition

What You Should Know:  - Today Thoma Bravo, a private equity software investment firm, announced a strategic growth investment in Bluesight, the Medication Intelligence™ Company. Current investor New Leaf Ventures will remain invested in the business. Financial terms of the transaction were not disclosed. - This investment will support Bluesight's acquisition of Medacist, the lead innovator in drug diversion monitoring, and drive the growth of Bluesight's inventory management and
Read More

Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B

by Fred Pennic 07/14/2023 Leave a Comment

Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B

What You Should Know:  Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases for $1.925B in cash. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab is currently being assessed in the BELIEVE Phase 2b study alone and in combination with
Read More

Causaly Secures $60M to Accelerate AI-Powered Biomedical Research

by Fred Pennic 07/13/2023 Leave a Comment

Causaly Secures $60M to Accelerate AI-Powered Biomedical Research

What You Should Know:  Causaly, the leading AI platform for biomedical research raises $60M in Series B funding led by ICONIQ Growth, with participation from Index Ventures, Marathon Venture Capital, EBRD, Pentech Ventures and Visionaries Club. Strategic individuals also participated in the round, including Alex Gorsky (former Chairman and CEO of Johnson & Johnson) and Olivier Pomel (CEO and Co-Founder of Datadog). The investment brings the total funding raised to $93 million,
Read More

Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices

by Fred Pennic 07/12/2023 Leave a Comment

Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices

What You Should Know:  The Israel Innovation Authority announced today a NIS 113M ($31M USD) investment for the establishment of a center that will provide research and development (R&D) infrastructure for bio-devices based on bio-chips. The investment is part of the National Bio-Convergence Program.Bio-convergence represents the integration of biology and life sciences with engineering and software technologies. The investment is directed at companies dedicated to developing key
Read More

Affect Therapeutics Secures $16M to Expand App for Drug and Alcohol Addiction

by Fred Pennic 07/12/2023 Leave a Comment

Affect Therapeutics Secures $16M to Expand App for Drug and Alcohol Addiction

What You Should Know:  Today, Affect Therapeutics - a McLean, VA-based company reimagining alcohol and drug addiction treatment with smartphone apps that put an integrated treatment program into the pocket of its members raises $16M in Series A funding led by ARTIS Ventures. The funding also included additional participation from previous investors AlleyCorp and CityLight, as well as new investments from LifeArc Ventures, Samsung Next, and What If Ventures. Founded in 2020, Affect
Read More

Fold Health Lands $6M for Optimization Platform for VBC Primary Care

by Fred Pennic 07/12/2023 Leave a Comment

Fold Health Lands $6M for Optimization Platform for VBC Primary Care

What You Should Know:  - Fold Health,a San Francisco, CA-based platform supporting value-based primary care raises $6M in funding from Iron Pillar and global angel investors.  - Fold partners with leading value-based primary care groups, ACOs, health systems, health plans and digital health companies, to 10x the reach and effectiveness of collaborative care teams in their mission to radically improve outcomes. Supercharge Primary Care Despite the rapid shift to value-based
Read More

Sequoia Project, AHIMA Launches Data Usability Initiative

by Fred Pennic 07/11/2023 Leave a Comment

Sequoia Project, AHIMA Launches Data Usability Initiative

What You Should Know:  The Sequoia Project and AHIMA, today announced the launch of a new initiative called Data Usability Taking Root to make health data more useful.  11 organizations have already committed to participating in the group and implementing and improving the best practices for data usability created over three years by 260+ Sequoia members. The organizations that have committed to implementing data usability include Azuba, Civitas Networks for Health, Epic, Foothold
Read More

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

by Fred Pennic 07/10/2023 Leave a Comment

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

What You Should Know:  Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies' multi-year partnership and research collaboration. The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle,
Read More

Verifiable Lands $27M to Automate Healthcare Provider Credentialing

by Fred Pennic 07/10/2023 Leave a Comment

Verifiable Lands $27M to Automate Healthcare Provider Credentialing

What You Should Know:  Verifiable,  an API-first innovator to the antiquated provider network management software category, has raised $27 million in Series B funding led by Craft Ventures to accelerate its next stage of growth and product innovation. Verifiable’s comprehensive suite of network management solutions and real-time verifications empowers healthcare organizations to expedite credentialing from multiple weeks to a matter of days. For customers, these efficiency gains can
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 216
  • Go to page 217
  • Go to page 218
  • Go to page 219
  • Go to page 220
  • Interim pages omitted …
  • Go to page 493
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |